Three more doses of Kovid-19 vaccine from Pfizer Inc. BioNTech SE were effective on Preventing symptomatic disease in children The ages in the study ranged from 6 months to 4 years, according to US health regulators.
FDA staff reviewing study data posted online on Sunday also said there were no new safety concerns in using the vaccine in younger children than in older age groups.